PMH38 A COST UTILITY ANALYSIS OF FIRST LINE ANTIPSYCHOTICS FOR THE PREVENTION OF SCHIZOPHRENIA RELAPSE IN THE UNITED KINGDOM
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72915-1
https://www.valueinhealthjournal.com/article/S1098-3015(11)72915-1/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
1071
First Page :
A452
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72915-1&doi=10.1016/S1098-3015(11)72915-1